Tetanus immunity in neonates in a developed country

Andrea-Romana Prusa1, Ursula Wiedermann, David C Kasper

  • 1Department of Pediatrics and Adolescent Medicine, Division of Paediatric Neonatology, Intensive Care and Neuropaediatry, Medical University of Vienna, Vienna, Austria.

Neonatology
|January 8, 2011
PubMed

Insights

Tetanus immunity was evaluated in Austrian newborns. Over 14% lacked adequate protection, highlighting the need for robust prenatal vaccination to safeguard infants.

Area of Science:

  • Immunology
  • Public Health

Background:

  • Industrialized nations have established vaccination programs, implying complete tetanus immunity in mothers and newborns.
  • Passive immunity is expected via transplacental transfer of maternal tetanus antibodies to offspring.

Purpose of the Study:

  • To assess seroprotection against tetanus in Austrian newborns.
  • To evaluate the effectiveness of maternal tetanus antibody transfer.

Main Methods:

  • Cord blood samples from 99 deliveries were collected.
  • Antibody concentrations against tetanus toxoid were measured using standardized ELISA.

Main Results:

  • 85.8% of newborns had protective tetanus antibody levels (≥0.1 IU/ml).
  • 9.1% showed low seropositivity, and 5.1% had no detectable tetanus antibodies.
  • The median antibody concentration was 0.95 IU/ml.

Conclusions:

  • A significant portion (14.2%) of newborns in Austria demonstrated inadequate tetanus immunity.
  • This underscores the importance of prenatal vaccination, even with widespread immunization programs.
  • Maternal immunization during pregnancy is recommended when indicated for newborn protection.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Tetanus01:29

Tetanus

Tetanus is a life-threatening neurological disorder characterized by persistent muscle contractions and spastic paralysis. It is caused by Clostridium tetani, a motile, Gram-positive, rod-shaped, obligate anaerobe. These bacteria produce terminal endospores, giving them a distinctive “lollipop” or “tennis-racket” appearance. They thrive in anaerobic environments, such as those found in deep puncture wounds.Once introduced into the body, the spores germinate into vegetative cells. These cells...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Active versus Passive Immunity01:31

Active versus Passive Immunity

Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
Vaccinations01:51

Vaccinations

Overview